Form D · Pharmaceuticals
PPC Pharmaceuticals, LLC
Los Angeles, CA · CIK 0001658289
Offering snapshot reported Nov 18, 2015 · SEC filing
- Reported sold
- $100K Offering amount: $100K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Nov 4, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 18, 2015 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $8K
- Finders' fees
- $0
- Form D file number
- 021-251454
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| CIRCLEUP | 161785 |
Source: Form D, filed Nov 18, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sarath Malepati | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
520 S Sepulveda Blvd, Suite 400
Los Angeles, CA, 90049
Los Angeles, CA, 90049